We The People USA

Citizens Dedicated To Preserving Our Constitutional Republic

Public Health and Medical Professionals for Transparency/Pfizer Documents

Source; https://phmpt.org/pfizers-documents/

Pfizer’s Documents


Views: 28

Reply to This

Replies to This Discussion

50 MORE FILES;

125742_S1_M5_c4591001-A-report-cci-lymphoma.pdfMarch 1, 2022640 KB

125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.pdfMarch 1, 2022636 KB

125742_S1_M5_c4591001-A-report-cci-mi.pdfMarch 1, 2022624 KB

125742_S1_M5_c4591001-A-report-cci-mild-liver.pdfMarch 1, 2022628 KB

125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.pdfMarch 1, 2022626 KB

125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.pdfMarch 1, 2022625 KB

125742_S1_M5_c4591001-A-report-cci-periph-vasc.pdfMarch 1, 2022632 KB

125742_S1_M5_c4591001-A-report-cci-pulmonary.pdfMarch 1, 2022630 KB

125742_S1_M5_c4591001-A-report-cci-renal.pdfMarch 1, 2022629 KB

125742_S1_M5_c4591001-A-report-cci-rheumatic.pdfMarch 1, 2022629 KB

125742_S1_M5_c4591001-T-S-final-reacto-tables-track.pdfMarch 1, 20222 MB

125742_S1_M5_c4591001-T-S-roadmap.pdfMarch 1, 2022703 KB

125742_S1_M5_c4591001-T-S-summary-differences-csr-vs-update.pdfMarch 1, 2022667 KB

125742_S1_M5_c4591001-T-S-suppl-arg.pdfMarch 1, 2022738 KB

125742_S1_M5_c4591001-T-S-updated-reacto-tlf.pdfMarch 1, 202217 MB

125742_S1_M5_CRF_c4591001 1001 10011093.pdfMay 2, 20223 MB

125742_S1_M5_CRF_c4591001 1001 10011100.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1001 10011135.pdfMay 2, 20221 MB

125742_S1_M5_CRF_c4591001 1003 10031038.pdfMay 2, 20223 MB

125742_S1_M5_CRF_c4591001 1003 10031065.pdfMay 2, 20223 MB

125742_S1_M5_CRF_c4591001 1003 10031111.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1003 10031113.pdfMay 2, 20223 MB

125742_S1_M5_CRF_c4591001 1003 10031149.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1003 10031186.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1003 10031197.pdfMay 2, 20221 MB

125742_S1_M5_CRF_c4591001 1003 10031207.pdfMay 2, 20221 MB

125742_S1_M5_CRF_c4591001 1005 10051047.pdfMay 2, 20221 MB

125742_S1_M5_CRF_c4591001 1005 10051054.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1005 10051069.pdfMay 2, 20221 MB

125742_S1_M5_CRF_c4591001 1005 10051214.pdfMay 2, 20221 MB

125742_S1_M5_CRF_c4591001 1005 10051293.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1005 10051347.pdfMay 2, 20221 MB

125742_S1_M5_CRF_c4591001 1005 10051387.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1005 10051411.pdfMay 2, 20221 MB

125742_S1_M5_CRF_c4591001 1006 10061020.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1006 10061040.pdfMay 2, 20224 MB

125742_S1_M5_CRF_c4591001 1006 10061052.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1006 10061094.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1006 10061098.pdfMay 2, 20222 MB

125742_S1_M5_CRF_c4591001 1006 10061176.pdfMay 2, 20223 MB

125742_S1_M5_CRF_c4591001-1085-10851018.pdfMarch 1, 20222 MB

125742_S1_M5_CRF_c4591001-1085-10851116.pdfMarch 1, 20221 MB

125742_S1_M5_CRF_c4591001-1085-10851129.pdfMarch 1, 20222 MB

125742_S1_M5_CRF_c4591001-1085-10851216March 1, 20221 MB

125742_S1_M5_CRF_c4591001-1085-10851246.pdfMarch 1, 20221 MB

5.2 listing of clinical sites and cvs pages 1-41.pdfNovember 17, 20218 MB

5.2 tabular listing.pdfNovember 17, 20212 MB

5.3.6 postmarketing experience.pdfNovember 17, 2021984 KB

BATES-92_adc19ef-ve-cov-7pd2-wo-eval-sas.txtNovember 17, 20219 KB

BATES-93_tv.xptNovember 17, 202116 KB

50 MORE FILES;

BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov-7pd2-eval-sas.txtDecember 13, 20219 KB

BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev-cov-7pd2-eval-sas.txtDecember 13, 20219 KB

BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev-cov-7pd2-wo-eval-sas.txtDecember 13, 20219 KB

BATES-FDA-CBER-2021-5683-0002375_addv-sas.txtDecember 13, 20215 KB

BATES-FDA-CBER-2021-5683-0002376_relrec.xptDecember 13, 2021567 KB

BATES-FDA-CBER-2021-5683-0002377_supppr.xptDecember 13, 202172 KB

BATES-FDA-CBER-2021-5683-0002378_ta.xptDecember 13, 20218 KB

BATES-FDA-CBER-2021-5683-0002379_te.xptDecember 13, 20213 KB

BATES-FDA-CBER-2021-5683-0002380_ti.xptDecember 13, 202137 KB

CRFs for site 1055.pdfDecember 13, 20216 MB

CRFs for site 1081.pdfDecember 30, 202113 MB

CRFs for site 1096.pdfJanuary 18, 202211 MB

CRFs for site 1128.pdfJanuary 31, 202214 MB

FDA CBER 2021 5683 0058316 to 0058458_125742_S1_M5_c4591001 A Supp define.xmlMay 2, 2022692 KB

FDA CBER 2021 5683 0058459 to 0058478_125742_S1_M5_c4591001 A Supp define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0058479 to 0058594_125742_S1_M5_c4591001 S define.xmlMay 2, 2022904 KB

FDA CBER 2021 5683 0058595 to 0058614_125742_S1_M5_c4591001 S define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0058615 to 0058652_125742_S1_M5_c4591001 S Supp define.xmlMay 2, 2022300 KB

FDA CBER 2021 5683 0058653 to 0058675_125742_S1_M5_c4591001 S Supp define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0058676 to 0058794_125742_S1_M5_bnt162 01 A define.xslMay 2, 2022828 KB

FDA CBER 2021 5683 0058795 to 0058828_125742_S1_M5_bnt162 01 A define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0058829 to 0058954_125742_S1_M5_bnt162 01 S define.xmlMay 2, 2022985 KB

FDA CBER 2021 5683 0058955 to 0058999_125742_S1_M5_bnt162 01 S define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0065774 to 0066700_125742_S1_M5_c4591001 A D addv.xptMay 2, 202244 MB

FDA-CBER-2021-5683-0021888 to -0021901_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf1-sas.txtMarch 1, 202214 KB

FDA-CBER-2021-5683-0021902 to -0021915_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf2-sasMarch 1, 202215 KB

FDA-CBER-2021-5683-0021916 to -0021929_125742_S1_M5_c4591001-A-P-adae-s092-all-unb-p3-saf-sasMarch 1, 202215 KB

FDA-CBER-2021-5683-0021930 to -0021943_125742_S1_M5_c4591001-A-P-adae-s092-cr-cut-p3x-saf-sasMarch 1, 202215 KB

FDA-CBER-2021-5683-0021944 to -0021963_125742_S1_M5_c4591001-A-P-adae-sasMarch 1, 202235 KB

FDA-CBER-2021-5683-0021964 to -0021980_125742_S1_M5_c4591001-A-P-adae-vax-tier2-p3-saf-sasMarch 1, 202218 KB

FDA-CBER-2021-5683-0021981 to -0022027_125742_S1_M5_c4591001-A-P-adc19ef-sasMarch 1, 202281 KB

FDA-CBER-2021-5683-0022028 to -0022040_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-sg-eval-sasMarch 1, 202220 KB

FDA-CBER-2021-5683-0022041 to -0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txtMarch 1, 202219 KB

FDA-CBER-2021-5683-0022054 to -0022062_125742_S1_M5_c4591001-A-P-adc19ef-ve-sev-cov-pd1-aai-sas.txtMarch 1, 202212 KB

FDA-CBER-2021-5683-0022063 to -0022135_125742_S1_M5_c4591001-A-P-adce-s010-lr-p3-saf-sas.txtMarch 1, 202272 KB

FDA-CBER-2021-5683-0022136 to -0022325_125742_S1_M5_c4591001-A-P-adce-s020-se-p3-saf-sas.txtMarch 1, 2022193 KB

FDA-CBER-2021-5683-0022326 to -0022345_125742_S1_M5_c4591001-A-P-adcevd-sas.txtMarch 1, 202227 KB

FDA-CBER-2021-5683-0022346 to -0022364_125742_S1_M5_c4591001-A-P-adcm-sas.txtMarch 1, 202232 KB

FDA-CBER-2021-5683-0022365 to -0022560_125742_S1_M5_c4591001-A-P-adds-s002-all-p3-rand-sas.txtMarch 1, 2022156 KB

FDA-CBER-2021-5683-0022561 to -0022567_125742_S1_M5_c4591001-A-P-adds-sas.txtMarch 1, 202211 KB

FDA-CBER-2021-5683-0022568 to -0022600_125742_S1_M5_c4591001-A-P-adfacevd-sas.txtMarch 1, 202249 KB

FDA-CBER-2021-5683-0022601 to -0022617_125742_S1_M5_c4591001-A-P-admh-sas.txtMarch 1, 202224 KB

FDA-CBER-2021-5683-0022618 to -0022691_125742_S1_M5_c4591001-A-P-adsl-demo-7d-eval-eff-sas.txtMarch 1, 202275 KB

FDA-CBER-2021-5683-0022692 to -0022765_125742_S1_M5_c4591001-A-P-adsl-demo-7d-wwo-eval-eff-sas.txtMarch 1, 202275 KB

FDA-CBER-2021-5683-0022766 to -0022792_125742_S1_M5_c4591001-A-P-adsl-fu-d2-p3-saf-sas.txtMarch 1, 202229 KB

FDA-CBER-2021-5683-0022793 to -0022866_125742_S1_M5_c4591001-A-P-adsl-s005-demo-all-p3-saf-sas.txtMarch 1, 202275 KB

FDA-CBER-2021-5683-0022867 to -0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txtMarch 1, 2022197 KB

FDA-CBER-2021-5683-0023007 to -0023031_125742_S1_M5_c4591001-A-P-adsympt-sas.txtMarch 1, 202243 KB

FDA-CBER-2021-5683-0023032 to -0023065_125742_S1_M5_c4591001-A-P-adva-sas.txtMarch 1, 202245 KB

FDA-CBER-2021-5683-0023455 to -0023486_125742_S1_M5_c4591001-A-define-2-0-0.xslMarch 1, 2022183 KB

50 M ORE FILES;

BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov-7pd2-eval-sas.txtDecember 13, 20219 KB

BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev-cov-7pd2-eval-sas.txtDecember 13, 20219 KB

BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev-cov-7pd2-wo-eval-sas.txtDecember 13, 20219 KB

BATES-FDA-CBER-2021-5683-0002375_addv-sas.txtDecember 13, 20215 KB

BATES-FDA-CBER-2021-5683-0002376_relrec.xptDecember 13, 2021567 KB

BATES-FDA-CBER-2021-5683-0002377_supppr.xptDecember 13, 202172 KB

BATES-FDA-CBER-2021-5683-0002378_ta.xptDecember 13, 20218 KB

BATES-FDA-CBER-2021-5683-0002379_te.xptDecember 13, 20213 KB

BATES-FDA-CBER-2021-5683-0002380_ti.xptDecember 13, 202137 KB

CRFs for site 1055.pdfDecember 13, 20216 MB

CRFs for site 1081.pdfDecember 30, 202113 MB

CRFs for site 1096.pdfJanuary 18, 202211 MB

CRFs for site 1128.pdfJanuary 31, 202214 MB

FDA CBER 2021 5683 0058316 to 0058458_125742_S1_M5_c4591001 A Supp define.xmlMay 2, 2022692 KB

FDA CBER 2021 5683 0058459 to 0058478_125742_S1_M5_c4591001 A Supp define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0058479 to 0058594_125742_S1_M5_c4591001 S define.xmlMay 2, 2022904 KB

FDA CBER 2021 5683 0058595 to 0058614_125742_S1_M5_c4591001 S define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0058615 to 0058652_125742_S1_M5_c4591001 S Supp define.xmlMay 2, 2022300 KB

FDA CBER 2021 5683 0058653 to 0058675_125742_S1_M5_c4591001 S Supp define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0058676 to 0058794_125742_S1_M5_bnt162 01 A define.xslMay 2, 2022828 KB

FDA CBER 2021 5683 0058795 to 0058828_125742_S1_M5_bnt162 01 A define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0058829 to 0058954_125742_S1_M5_bnt162 01 S define.xmlMay 2, 2022985 KB

FDA CBER 2021 5683 0058955 to 0058999_125742_S1_M5_bnt162 01 S define 2 0 0.xslMay 2, 2022183 KB

FDA CBER 2021 5683 0065774 to 0066700_125742_S1_M5_c4591001 A D addv.xptMay 2, 202244 MB

FDA-CBER-2021-5683-0021888 to -0021901_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf1-sas.txtMarch 1, 202214 KB

FDA-CBER-2021-5683-0021902 to -0021915_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf2-sasMarch 1, 202215 KB

FDA-CBER-2021-5683-0021916 to -0021929_125742_S1_M5_c4591001-A-P-adae-s092-all-unb-p3-saf-sasMarch 1, 202215 KB

FDA-CBER-2021-5683-0021930 to -0021943_125742_S1_M5_c4591001-A-P-adae-s092-cr-cut-p3x-saf-sasMarch 1, 202215 KB

FDA-CBER-2021-5683-0021944 to -0021963_125742_S1_M5_c4591001-A-P-adae-sasMarch 1, 202235 KB

FDA-CBER-2021-5683-0021964 to -0021980_125742_S1_M5_c4591001-A-P-adae-vax-tier2-p3-saf-sasMarch 1, 202218 KB

FDA-CBER-2021-5683-0021981 to -0022027_125742_S1_M5_c4591001-A-P-adc19ef-sasMarch 1, 202281 KB

FDA-CBER-2021-5683-0022028 to -0022040_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-sg-eval-sasMarch 1, 202220 KB

FDA-CBER-2021-5683-0022041 to -0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txtMarch 1, 202219 KB

FDA-CBER-2021-5683-0022054 to -0022062_125742_S1_M5_c4591001-A-P-adc19ef-ve-sev-cov-pd1-aai-sas.txtMarch 1, 202212 KB

FDA-CBER-2021-5683-0022063 to -0022135_125742_S1_M5_c4591001-A-P-adce-s010-lr-p3-saf-sas.txtMarch 1, 202272 KB

FDA-CBER-2021-5683-0022136 to -0022325_125742_S1_M5_c4591001-A-P-adce-s020-se-p3-saf-sas.txtMarch 1, 2022193 KB

FDA-CBER-2021-5683-0022326 to -0022345_125742_S1_M5_c4591001-A-P-adcevd-sas.txtMarch 1, 202227 KB

FDA-CBER-2021-5683-0022346 to -0022364_125742_S1_M5_c4591001-A-P-adcm-sas.txtMarch 1, 202232 KB

FDA-CBER-2021-5683-0022365 to -0022560_125742_S1_M5_c4591001-A-P-adds-s002-all-p3-rand-sas.txtMarch 1, 2022156 KB

FDA-CBER-2021-5683-0022561 to -0022567_125742_S1_M5_c4591001-A-P-adds-sas.txtMarch 1, 202211 KB

FDA-CBER-2021-5683-0022568 to -0022600_125742_S1_M5_c4591001-A-P-adfacevd-sas.txtMarch 1, 202249 KB

FDA-CBER-2021-5683-0022601 to -0022617_125742_S1_M5_c4591001-A-P-admh-sas.txtMarch 1, 202224 KB

FDA-CBER-2021-5683-0022618 to -0022691_125742_S1_M5_c4591001-A-P-adsl-demo-7d-eval-eff-sas.txtMarch 1, 202275 KB

FDA-CBER-2021-5683-0022692 to -0022765_125742_S1_M5_c4591001-A-P-adsl-demo-7d-wwo-eval-eff-sas.txtMarch 1, 202275 KB

FDA-CBER-2021-5683-0022766 to -0022792_125742_S1_M5_c4591001-A-P-adsl-fu-d2-p3-saf-sas.txtMarch 1, 202229 KB

FDA-CBER-2021-5683-0022793 to -0022866_125742_S1_M5_c4591001-A-P-adsl-s005-demo-all-p3-saf-sas.txtMarch 1, 202275 KB

FDA-CBER-2021-5683-0022867 to -0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txtMarch 1, 2022197 KB

FDA-CBER-2021-5683-0023007 to -0023031_125742_S1_M5_c4591001-A-P-adsympt-sas.txtMarch 1, 202243 KB

FDA-CBER-2021-5683-0023032 to -0023065_125742_S1_M5_c4591001-A-P-adva-sas.txtMarch 1, 202245 KB

FDA-CBER-2021-5683-0023455 to -0023486_125742_S1_M5_c4591001-A-define-2-0-0.xslMarch 1, 2022183 KB

FINAL FILES;

FDA-CBER-2021-5683-0023490 to -0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale.xlsxMarch 1, 202213 KB

FDA-CBER-2021-5683-0023490 to -0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale.xlsxMarch 1, 202213 KB

FDA-CBER-2021-5683-0023500 to -0023507_125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.xlsxMarch 1, 202229 KB

FDA-CBER-2021-5683-0023523 to -0023538_125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.xlsxMarch 1, 202218 KB

FDA-CBER-2021-5683-0023540_125742_S1_M5_c4591001-A-comorbidity-categories.xlsxMarch 1, 202219 KB

FDA-CBER-2021-5683-0023550 to -0023569_125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.xlsxMarch 1, 202222 KB

FDA-CBER-2021-5683-0023711 to -0023875_125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.xlsxMarch 1, 202284 KB

FDA-CBER-2021-5683-0023878_125742_S1_M5_c4591001-A-report-cci-aids-hiv.xlsxMarch 1, 202223 KB

FDA-CBER-2021-5683-0023895 to -0023915_125742_S1_M5_c4591001-A-report-cci-any-malignancy.xlsxMarch 1, 202235 KB

FDA-CBER-2021-5683-0023919 to -0023921_125742_S1_M5_c4591001-A-report-cci-cerebrovascular.xlsxMarch 1, 202212 KB

FDA-CBER-2021-5683-0023924_125742_S1_M5_c4591001-A-report-cci-chf.xlsxMarch 1, 202210 KB

FDA-CBER-2021-5683-0023926_125742_S1_M5_c4591001-A-report-cci-dementia.xlsxMarch 1, 20229 KB

FDA-CBER-2021-5683-0023928_125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.xlsxMarch 1, 20229 KB

FDA-CBER-2021-5683-0023930_125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.xlsxMarch 1, 202210 KB

FDA-CBER-2021-5683-0023932_125742_S1_M5_c4591001-A-report-cci-hemiplegia.xlsxMarch 1, 202210 KB

FDA-CBER-2021-5683-0023936 to -0023937_125742_S1_M5_c4591001-A-report-cci-leukemia.xlsxMarch 1, 202212 KB

FDA-CBER-2021-5683-0023944 to -0023950_125742_S1_M5_c4591001-A-report-cci-lymphoma.xlsxMarch 1, 202217 KB

FDA-CBER-2021-5683-0023955 to -0023958_125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.xlsxMarch 1, 202214 KB

FDA-CBER-2021-5683-0023960_125742_S1_M5_c4591001-A-report-cci-mi.xlsxMarch 1, 20229 KB

FDA-CBER-2021-5683-0023963_125742_S1_M5_c4591001-A-report-cci-mild-liver.xlsxMarch 1, 202210 KB

FDA-CBER-2021-5683-0023965_125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.xlsxMarch 1, 20229 KB

FDA-CBER-2021-5683-0023967_125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.xlsxMarch 1, 20229 KB

FDA-CBER-2021-5683-0023971 to -0023972_125742_S1_M5_c4591001-A-report-cci-periph-vasc.xlsxMarch 1, 202212 KB

FDA-CBER-2021-5683-0023975 to -0023976_125742_S1_M5_c4591001-A-report-cci-pulmonary.xlsxMarch 1, 202212 KB

FDA-CBER-2021-5683-0023979 to -0023980_125742_S1_M5_c4591001-A-report-cci-renal.xlsxMarch 1, 202211 KB

FDA-CBER-2021-5683-0023983 to -0023984_125742_S1_M5_c4591001-A-report-cci-rheumatic.xlsxMarch 1, 202224 KB

FDA-CBER-2021-5683-0023987_125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.xlsxMarch 1, 202221 KB

FDA-CBER-2021-5683-0059000 to -0065773_125742_S1_M5_c4591001-A-D-adcevd.zip (.xpt)May 2, 20229 MB

FDA-CBER-2021-5683-0066701-to-0123167_125742_S1_M5_c4591001-A-D-adfacevd.zip (.xpt)May 2, 202281 MB

FDA-CBER-2021-5683-0123168-to-0126026_125742_S1_M5_c4591001-A-D-adva.zip (.xpt)May 2, 20227 MB

Pages 42-289-Section 5.2 – listing-clinical-sites-cvs_Part A.pdfDecember 1, 202112 MB

Pages 42-289-Section 5.2 – listing-clinical-sites-cvs_Part B.pdfDecember 1, 202114 MB

reissue_5.3.6 postmarketing experience.pdfApril 1, 2022958 KB

signed F21-5683 CBER Dec 13 2021 Response Letter.pdfDecember 13, 2021207 KB

STN 125742_0_0 Section 2.5 Clinical Overview.pdfDecember 13, 20214 MB

STN 125742_0_0 Section 2.7.3 Summary of Clinical Efficacy.pdfDecember 13, 20213 MB

STN 125742_0_0 Section 2.7.4 summary-clin-safety.pdfDecember 13, 20216 MB

Supplemental Index 12-22-21.pdfDecember 22, 20212 MB

RSS

Badge

Loading…

Online Magazines

Accuracy In Media
American Spectator
American Thinker
American Conservative
Amer Conservative Daily
The American Prospect
Atlanta Const Journal
The Atlantic Monthly
Boston Review
Blacklisted News
The Bulletin
Canada Free Press
Capitalism Magazine
Chronicles Magazine
City Journal
CNS News
CNIN Truth
Conservative Economist
Consortium News
Commentary Magazine
The Conservative Edge
Conservative Outpost
Corruption Chronicals (JW)
The Corzine Times
CounterPunch
The Daily Caller
Daily Mail UK
Deep Journal
Digital Journal
Dissent Magazine
The Economist
Examiner
Florida Pundit
Foreign Affairs
Foreign Policy
The Freemen Institute
The Gouverneur Times NY
The Guardian UK
The Foundry (Heritage)
Free Market News
FrontPage Magazine
Gateway Pundit
The Guardian UK
The Globalist
Harper's Magazine
Harvard Inter Review
The Hill
Human Events
In These Times
The Land of the Free
Liberty Unbound
Mission America
Mother Jones
Monthly Review
The Nation
National Interest
National Ledger
National Review
New Internationalist
The New American
The New Ledger
New Left Review
New Media Journal
News Hounds
Newstin
The New Republic
News Busters
News Fifty
NewsMax
Newsweek
News Daily
News With Views
Online Journal
Oohja.com
The Palestine Chronicle
Planet Daily
Policy Review
Poligazette
Politics Daily
The Post Chronicle
Pravda
The Progressive
Reality Check
The Real News Network
Reason
Real Clear Markets
Real Clear Politics
Red Pepper
Roll Call
Russia Today
Salon
Slate
Spectator Magazine
Spiked
Telegraph UK
Time
Toward Freedom
Townhall
U.S. News & World Report
Utne Reader
Wall Street Journal Magazine
Washington Examiner
The Washington Independent
Washington Monthly
The Weekly Standard
World Net Daily
World Magazine
World Press Review
World Reports
World Tribune
Vanity Fair

© 2024   Created by WTPUSA.   Powered by

Badges  |  Report an Issue  |  Terms of Service